Meeting
2020 ASCO Virtual Scientific Program
Impact of an immuno-oncology (IO) education/monitoring program on patient’s self-efficacy and adverse event reporting from immune checkpoint inhibitors (ICIs).
Authors
Parneet Kaur Cheema
William Osler Health System, University of Toronto, Brampton, ON, Canada
Parneet Kaur Cheema , Massey Nematollahi , FeRevelyn Berco , Janet Papadakos , Deepanjali Kaushik , Priscilla Matthews , Marco Iafolla , Kirstin Perdrizet , Margaret Balcewicz , William Raskin , Stephen Reingold , Juhi Husain , Philip Kuruvilla , Henry Jacob Conter
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Care Delivery
Citation
J Clin Oncol 38: 2020 (suppl; abstr 2032)
DOI
10.1200/JCO.2020.38.15_suppl.2032
Abstract #
2032
Poster Bd #
24
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The study of immune-related adverse events in a community-based centre.
First Author: Sandhya Cautha
Poster
2023 ASCO Annual Meeting
Immune-related adrenal insufficiency: A single center retrospective analysis.
First Author: Natalya Polshina
Poster
2022 ASCO Quality Care Symposium
The Inpatient Immunotherapy Outcomes study: A multicenter retrospective study of patients treated with immune checkpoint inhibitors in the inpatient setting.
First Author: Fauzia Riaz
Poster
2022 ASCO Annual Meeting
Association between immune-related adverse events and microbiome composition in patients with advanced non–small cell lung cancer treated with immunotherapy.
First Author: Marion Tonneau